10 firms writing Biotech checks in San Francisco, led by Sofinnova Investments, AME Cloud Ventures.
Biotech in San Francisco accounts for 25 tracked companies with verified cap-table data, 25 of which disclose round sizes totalling $5.1B. The median disclosed raise is $165M, and the largest is Xaira Therapeutics at $1B, ahead of NewLimit ($682M) and Delfi Diagnostics ($400M).
The names that recur most often on these biotech cap tables are Founders Fund (3 companies), Cultivian Sandbox Ventures (3 companies), SOSV (3 companies), Lux Capital (3 companies), Kleiner Perkins (2 companies), Eli Lilly (2 companies). By latest disclosed round, the market skews Series B (8), Series A (6), Series C (3), Series D (3).
All research · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide